Development of a hyaluronan targeted contrast reagent for the demarcation of melanoma margins in vivo [6]

Journal of Investigative Dermatology

Volumn 128, Issue 3, 2008, Pages 740-742

  Rudrabhatla, S R ^a   Petroll, W Matthew ^a   Mahaffey, Christie L ^a   Mummert, Mark E ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GREEN FLUORESCENT PROTEIN; HYALURONIC ACID; HYALURONIC ACID BINDING PROTEIN; ISOTHIOCYANIC ACID; PEP 1 PROTEIN; TETRAMETHYLRHODAMINE; TETRAMETHYLRHODAMINE ISOTHIOCYANATE PEP 1 PROTEIN I 125; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CONJUGATION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG BINDING; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG TARGETING; EAR; LETTER; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN EXPRESSION; SKIN; TUMOR BIOPSY;

ANIMALS; BIOPSY; CONTRAST MEDIA; CYSTEAMINE; HYALURONIC ACID; IODINE RADIOISOTOPES; MELANOMA; MICE; PEPTIDES; SKIN NEOPLASMS;

EID: 39149088310     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5701097     Document Type: Letter

References (15)

1. Becker A, Hessenius C, Licha K, Ebert B, Sukowski U, Semmler W et al. (2001) Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol 19:327-31
2. Chen CSJ, Elias M, Busam K, Rajadhyaksha M, Marghoob AA (2005) Multimodal in vivo optical imaging, including confocal microscopy, facilitates presurgical margin mapping for clinically complex lentigo maligna melanoma. Br J Dermatol 153:1031-6
3. Curiel-Lewandrowski C, Williams CM, Swindells KJ, Tahan SR, Astner S, Frankenthaler RA et al. (2004) Use of in vivo confocal microscopy in malignant melanoma: an aid in diagnosis and assessment of surgical and nonsurgical therapeutic approaches. Arch Dermatol 140:1127-32
4. Karjalainen JM, Tammi RH, Tammi MI, Eskelinen MJ, Agren UM, Parkkinen JJ et al. (2000) Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma. Am J Pathol 157:957-65
5. Li YY, Gonzalez S, Terwey TH, Wolchok J, Li YB, Aranda L et al. (2005) Dual mode reflectance and fluorescence confocal laser scanning microscopy for in vivo imaging melanoma progression in murine skin. J Invest Dermatol 125:798-804
6. Lundqvist H, Tolmachev V (2002) Targeting peptides and positron emission tomography. Biopolymers 66:381-92
7. Mahmood U, Tung CH, Bogdanov A Jr, Weissleder R (1999) Near-infrared optical imaging of protease activity for tumor detection. Radiology 213:866-70
8. Marra DE, Torres A, Schanbacher CF, Gonzalez S (2005) Detection of residual basal cell carcinoma by in vivo confocal microscopy. Dermatol Surg 31:538-41
9. McIntyre JO, Fingleton B, Wells KS, Piston DW, Lynch CC, Gautam S et al. (2004) Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity. Biochem J 377:617-28
10. Rudrabhatla SR, Mahaffey CL, Mummert ME (2006) Tumor microenvironment modulates hyaluronan expression: the lactate effect. J Invest Dermatol 126:1378-87
11. Tannous Z, Torres A, Gonzalez S (2003) In vivo real-time confocal reflectance microscopy: a noninvasive guide for mohs micrographic surgery facilitated by aluminum chloride, an excellent contrast enhancer. Dermatol Surg 29:839-46
12. Walenta S, Doetsch J, Mueller-Klieser W, Kunz-Schughart LA (2000) Metabolic imaging in multicellular spheroids of oncogene-transfected fibroblasts. J Histochem Cytochem 48:509-22
13. Ye YP, Bloch S, Xu BG, Achilefu S (2006) Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors. J Med Chem 49:2268-75
14. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. J Nucl Med 47:492-501
15. Zmolik JM, Mummert ME (2005) Pep-1 as a novel probe for the in situ detection of hyaluronan. J Histochem Cytochem 53:745-52